Five-year survival rates for patients (pts) with metastatic melanoma (MM) treated with ipilimumab (IPI) in phase II trials Meeting Abstract


Authors: Lebbé, C.; Weber, J. S.; Maio, M.; Neyns, B.; Harmankaya, K.; Chin, K.; McDowell, D. O.; Cykowski, L.; McHenry, M. B.; Wolchok, J. D.
Abstract Title: Five-year survival rates for patients (pts) with metastatic melanoma (MM) treated with ipilimumab (IPI) in phase II trials
Meeting Title: 37th Congress of the European Society for Medical Oncology (ESMO)
Journal Title: Annals of Oncology
Volume: 23
Issue: Suppl. 9
Meeting Dates: 2012 Sep 28-Oct 2
Meeting Location: Vienna, Austria
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2012-09-01
Start Page: ix363
End Page: ix364
Language: English
ACCESSION: WOS:000309409002054
PROVIDER: wos
PUBMED: 23012731
DOI: 10.1016/S0923-7534(20)33684-X
Notes: Meeting Abstract: 1116PD -- "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok